International, Peer Reviewed, Open Access Journal

Journal of Clinical Pharmacology and Therapeutics
(ISSN: 2766-8347)

Submit Manuscript

Journal of Clinical Pharmacology and Therapeutics

Journal of Clinical Pharmacology and Therapeutics is an open access peer reviewed journal which provides latest updates in treatments, advanced procedures, technologies associated within the field of Pharmacology and other related sub-divisions.

Journal Features

Open Access

All the articles will be published under Open Access model.

Peer Review

Our editorial team performs strict peer-review process.

Publication Ethics

The journal follows standard guidelines to maintain transparency.

Submit Manuscript

The journal accepts all original articles, reviews and more.

About the Journal

Journal of Clinical Pharmacology and Therapeutics provide reports on optimal clinical use of various drugs and effects in treatment of patients.

Open Access - Journal of Clinical Pharmacology and Therapeutics

Editorial Board

Sana Irfan Khan - Journal of Clinical Pharmacology and Therapeutics

Sana Irfan Khan

Volunteering as a peer reviewer for submitted manuscripts
United States

ÖMER ALKAN - Journal of Clinical Pharmacology and Therapeutics

ÖMER ALKAN

Associate professor in the department of econometrics
Turkey

Bruno Trimarco - Journal of Clinical Pharmacology and Therapeutics

Bruno Trimarco

Federico II University of Naples (www.unina.it)
Federico II University of Naples, Director of Division of Cardiology, Coronary care unit and Cat Lab Business or sector Medical

Italy

Athanasia Papazafiropoulou - Journal of Clinical Pharmacology and Therapeutics

Athanasia Papazafiropoulou

General Hospital of Piraeus “Tzaneio”, 1st Department of Internal Medicine
Greece

Articles

J Clin Pharmacol Ther. 2021;2(2):JCPT-02-1017 | Open Access

Prevalence of Polypharmacy and Potentially Inappropriate Medications in Elderly Patients: Cross Sectional Study Based on Updated Beer’s Criteria 2019

Ankit Bhardwaj

Background: Polypharmacy, contribute to increase risk of adverse drug reaction morbidity, mortality, increase length of hospital stay, hospital revisits and readmissions. We aimed to evaluate the prevalence and trends of polypharmacy and Potentially Inappropriate Medications (PIMs) in elderly patients using updates Beers Criteria 2019. We try to assess the severity of adverse drug events using modified Hartwig and Siegel scale in ... Read more

RESEARCH ARTICLE Updated Aug 06, 2021   PDF

J Clin Pharmacol Ther. 2021;2(2):JCPT-02-1016 | Open Access

Levetiracetam Population Pharmacokinetic in North Indian Epilepsy Patients

Ankit Bhardwajand Sangeeta Sharma

Background: Unlike first line Antiepileptic Drugs (AEDs) specific therapeutic range for Levetiracetam (LEV) has not been defined. The present study was conducted to find the mean serum LEV levels using population pharmacokinetics and to find out the correlation with the demographic and physiological determinants (age, gender, weight and dose) and concomitant antiepileptics drugs in the north Indian population.
Methods: ... Read more

RESEARCH ARTICLE Updated Aug 06, 2021   PDF

J Clin Pharmacol Ther. 2021;2(2):JCPT-02-1015 | Open Access

Knowledge, Attitude, Perception and Practice of Pharmacy Students Concerning Antibiotic Use and Antibiotic Resistance

Palanisamy Sivanandy and Tan Si Jie

Background: Antibiotic resistance is an alarming situation in the healthcare sector, where the practice of healthcare professionals plays a vital role in preventing antibiotics-related harm. A cross-sectional study was conducted to analyze the knowledge, attitude, perception, and practice of antibiotic use and resistance among the final year pharmacy students of a Malaysian private medical university. Methods: A cross-sectional study was ... Read more

RESEARCH ARTICLE Updated Jul 30, 2021   PDF

J Clin Pharmacol Ther. 2021;2(1):JCPT-02-1014 | Open Access

Knowledge Attitude and Practice Study of Pharmacogenomics amongst Physicians of a Major Indian Metropolitan City

Sharanya Shre ES, Ravi S and Ezhil Arasan R

Pharmacogenomics is a field with a futuristic goal of providing personalized medicine based on an individual’s genetic makeup. The field experiences an exponential growth of evidence and research that could enable physicians to to prescribe medicines to treat underlying conditions while enhancing the predictability of adverse reactions and efficacy of a drug for an individual. With the continued ... Read more

RESEARCH ARTICLE Updated Jul 13, 2021   PDF

J Clin Pharmacol Ther. 2021;2(1):JCPT-02-1013 | Open Access

Dasatinib Induced Pulmonary Arterial Hypertension and Pleural Effusion in Post allogenic Stem Cell Transplant CML Patient

Muniza Bai, Pratap Upadhya, Lakshmi Sandhya, Manju Rajaram and Biswajit Dubashi

Though Dasatinib is a second-generation tyrosine kinase inhibitor used for the first line therapy of CML, it is associated with the risk of pulmonary hypertension and pleural effusion. Pleural effusion due to Dasatinib is often reversible unlike pulmonary hypertension. Asymptomatic pleural effusion warrants only conservative management and regular follow up. For symptomatic effusions, dose reduction or dose interruption is recommended. ... Read more

CASE REPORT Updated Jul 07, 2021   PDF